Nilotinib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Nilotinib is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old. Nilotinib is usually given after other medications have been tried without success. More info »
Al estar en nuestro sitio web, Usted automáticamente acepta el almacenamiento y procesamiento de sus datos personales, según nuestra Política de privacidad.
Denmark
Finland
Norway
Sweden